Breaking News

Waters Acquires Halo Labs, Expands Biologic Analysis Portfolio

Gains Halo’s Aura platform, a highly differentiated technology that performs full spectrum particle analysis.

Waters Corp. has acquired Halo Labs, a company specialized in imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies. Halo’s Aura platform features a highly differentiated technology that performs full spectrum particle analysis and is complementary to the Waters light scattering detection solutions from its Wyatt Technology Portfolio. For example, its subvisible particle technology provides addi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters